The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of p28 (NSC745104), a non-HDM2 mediated peptide inhibitor of p53 ubiquitination in children with recurrent or progressive CNS tumors: A final report from the Pediatric Brain Tumor Consortium.
 
Rishi Ramesh Lulla
No Relationships to Disclose
 
Stewart Goldman
Consulting or Advisory Role - Celgene; Novartis
 
Craig Beattie
Employment - CDG Therapeutics
Leadership - CDG Therapeutics
Research Funding - University of Illinois
 
Tohru Yamada
Employment - CDG Therapeutics
Patents, Royalties, Other Intellectual Property - CDG Therapeutics
 
Ian Pollack
No Relationships to Disclose
 
Paul Graham Fisher
Stock and Other Ownership Interests - Johnson & Johnson
Other Relationship - The Journal of Pediatrics
 
Shengjie Wu
No Relationships to Disclose
 
James M. Boyett
No Relationships to Disclose
 
Maryam Fouladi
Research Funding - Genentech